CCT3 drives Sorafenib resistance by inhibiting TFRC-mediated iron uptake in HCC
H. Zhu, Q. Liu, Q. Meng, L. Zhang, J. Lan, D. Zhu, Y. Chen, N. Aishan, X. Ouyang, S. Zhang, L. Jin, L. Xiao, L. Wang, L. Li, F. Ji
This study identifies CCT3 as a driver of Sorafenib resistance in HCC by inhibiting TFRC-mediated iron uptake, leading to ferroptosis resistance.
bioRxiv · Dec 14, 2023 · PreprintCancer Biology